Cargando…
Comparative strategies for stem cell biodistribution in a preclinical study
Stem cell therapy represents the potential alternative effective strategy for some diseases that lack effective treatment currently. Correspondingly, it is crucial to establish high-sensitive and reliable quantification assay for tracing exogenous cell migration. In the present study, we first used...
Autores principales: | Wang, Fang, Wang, Zhe, Wang, Fen, Dong, Kelly, Zhang, Jing, Sun, Yun-juan, Liu, Chun-feng, Xing, Mei-jie, Cheng, Xue, Wei, Su, Zheng, Jia-wei, Zhao, Xiong-fei, Wang, Xiao-ming, Fu, Jie, Song, Hai-feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470780/ https://www.ncbi.nlm.nih.gov/pubmed/31705124 http://dx.doi.org/10.1038/s41401-019-0313-x |
Ejemplares similares
-
Biodistribution of Mesenchymal Stem/Stromal Cells in a Preclinical Setting
por: Sensebé, Luc, et al.
Publicado: (2013) -
Preclinical Study on Biodistribution of Mesenchymal Stem Cells after Local Transplantation into the Brain
por: Bashyal, Narayan, et al.
Publicado: (2023) -
Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics
por: Vervaeke, P., et al.
Publicado: (2022) -
Preclinical Pharmacokinetics, Biodistribution, and Acute Toxicity Evaluation of Caerin 1.9 Peptide in Sprague Dawley Rats
por: Yang, Xiaodan, et al.
Publicado: (2022) -
Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic
por: Richter, Maximilian, et al.
Publicado: (2016)